Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients
Phase of Trial: Phase IV
Latest Information Update: 12 Sep 2016
At a glance
- Drugs Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 26 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
- 10 May 2016 Status changed from not yet recruiting to recruiting.
- 16 Dec 2015 Planned initiation date changed from 1 Feb 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov